Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device.
The Food and Drug Administration has confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical device sold in the U.S.
Despite the lack of clearance, the FDA said doctors should continue using the device because it’s not clear that a federal review would have prevented the recent infections.
Olympus has now submitted an application for the device that is currently under FDA review
Was this article valuable?
Here are more articles you may enjoy.
Illinois Passes Legislation to Give Insurance Department Oversight of Rate Changes 
USI Insurance Services Claims Ex-Broker Poached Clients for Own New Agency 
Shipper Escapes $41.9M Award for Man Paralyzed When Lights Fell From Pallet on Him 
Georgia Brokers and Agents Alarmed After Court Ruling Expands Liability for Them 
